A patient with hypertension presents with a blood pressure of 160/100 mmHg, headaches, dizziness, and mild pedal edema. Her laboratory results show elevated creatinine and LDL cholesterol levels. A 12-lead ECG indicates left ventricular hypertrophy. Which nursing intervention is most appropriate to prioritize to address her current condition?

A) Educate the patient on reducing sodium intake to manage blood pressure and decrease edema.

B) Advise the patient to increase fluid intake to enhance renal function.

C) Instruct the patient to avoid all physical activity to prevent further cardiac stress.

D) Recommend the patient to discontinue all antihypertensive medications until follow-up.

A 58-year-old female patient with a history of hypertension presents with a blood pressure of 160/100 mmHg, headaches, dizziness, and occasional chest discomfort. Her current medication includes Lisinopril. Laboratory tests show elevated creatinine levels and LDL cholesterol, and an ECG indicates left ventricular hypertrophy. Which nursing intervention is most appropriate to prioritize in managing this patient's condition?

A) Educate the patient on reducing dietary sodium intake to manage blood pressure.

B) Monitor the patient’s urine output to assess renal function.

C) Increase the dosage of Lisinopril to better control blood pressure.

D) Advise the patient to take over-the-counter analgesics for headache relief.

A patient with hypertension has been prescribed amlodipine and an increased dose of Lisinopril. During a follow-up visit, she reports increased fatigue and mild shortness of breath upon exertion. What is the most appropriate nursing intervention to perform next?

B) Assess the patient for signs of heart failure

A) Instruct the patient to increase her daily fluid intake

B) Assess the patient for signs of heart failure

C) Encourage more vigorous physical activity to improve stamina

D) Educate the patient about potential side effects of the medications

A patient with newly diagnosed heart failure with reduced ejection fraction (HFrEF) has been started on carvedilol. Which nursing intervention is most important to implement during the initial phase of treatment?

B) Monitor the patient's heart rate and blood pressure closely.

A) Encourage the patient to increase fluid intake to prevent dehydration.

B) Monitor the patient's heart rate and blood pressure closely.

C) Advise the patient to discontinue low-sodium diet to prevent electrolyte imbalance.

D) Instruct the patient to perform vigorous exercise to improve cardiac function.

A patient with heart failure with reduced ejection fraction (HFrEF) is initiated on carvedilol as part of their treatment plan. What is the primary nursing consideration when initiating carvedilol therapy in this patient?

B) Monitoring for signs of bradycardia and adjusting the dose accordingly.

A) Assessing renal function to prevent acute kidney injury.

B) Monitoring for signs of bradycardia and adjusting the dose accordingly.

C) Evaluating for potential interactions with the patient's existing antihypertensive medications.

D) Encouraging increased fluid intake to prevent dehydration.

A patient on carvedilol reports dizziness upon standing and has a blood pressure of 110/70 mmHg. Which nursing intervention is most appropriate to prevent injury from orthostatic hypotension?

B) Advise the patient to rise slowly from a sitting or lying position.

A) Encourage the patient to increase fluid intake to raise blood pressure.

B) Advise the patient to rise slowly from a sitting or lying position.

C) Instruct the patient to increase salt intake to improve blood volume.

D) Suggest the patient engage in vigorous exercise to enhance circulation.

A patient who recently started carvedilol therapy presents with dizziness on standing and a decrease in heart rate. Based on this assessment, which nursing intervention should be prioritized to address the patient's current symptoms and prevent further complications?

A) Educate the patient about the importance of standing up slowly to prevent dizziness.

B) Instruct the patient to increase fluid intake to manage potential dehydration.

C) Suggest reducing physical activity to minimize cardiac strain.

D) Recommend increasing dietary salt to help raise blood pressure.

A patient with heart failure returns for a follow-up visit. The nurse notes a decrease in blood pressure, persistent dizziness, and occasional palpitations. The patient's lab results show a mild decrease in serum potassium. Which nursing intervention is most appropriate to address the patient's current symptoms and lab findings?

C) Advise the patient to rise slowly from a sitting or lying position to reduce dizziness.

A) Increase the patient's carvedilol dosage to stabilize her heart rate.

B) Educate the patient on increasing dietary potassium intake and monitor for signs of hyperkalemia.

C) Advise the patient to rise slowly from a sitting or lying position to reduce dizziness.

D) Suggest discontinuing all antihypertensive medications to prevent further hypotension.

A patient with heart failure and hypertension is experiencing orthostatic hypotension and occasional palpitations during physical exertion. Her lab results show a decrease in serum potassium levels to 3.4 mEq/L and an increase in BNP levels. The healthcare team is considering adjusting her carvedilol dosage and adding a low-dose potassium-sparing diuretic. Which nursing intervention is most appropriate to address the patient's current symptoms and laboratory findings?

B) Educate the patient on orthostatic hypotension management strategies and monitor her potassium levels closely.

A) Encourage the patient to increase her fluid intake to improve blood pressure and prevent dizziness.

B) Educate the patient on orthostatic hypotension management strategies and monitor her potassium levels closely.

C) Advise the patient to reduce physical activity to minimize palpitations and prevent further cardiovascular strain.

D) Suggest the patient increase dietary sodium to help raise blood pressure and alleviate symptoms of hypotension.

Hypertension - Nursing Case Study

Pathophysiology

• Primary mechanism: Increased peripheral resistance - Hypertension often results from elevated resistance in the arterioles, primarily due to vasoconstriction, structural changes in vessel walls, or both. This causes the heart to work harder to pump blood, raising blood pressure.

• Secondary mechanism: Renin-angiotensin-aldosterone system (RAAS) dysregulation - Overactivation of RAAS leads to increased blood volume and vasoconstriction. Angiotensin II causes blood vessels to narrow, while aldosterone prompts the kidneys to retain sodium and water, both contributing to elevated blood pressure.

• Key complication: End-organ damage - Sustained high blood pressure can cause damage to vital organs such as the heart, kidneys, brain, and eyes, potentially leading to conditions like heart failure, renal impairment, stroke, and retinopathy if not managed effectively.

Patient Profile

Demographics:

55-year-old female, office manager

History:

• Key past medical history: Hypertension diagnosed 5 years ago, family history of cardiovascular disease

• Current medications: Lisinopril 10 mg daily, Hydrochlorothiazide 25 mg daily

• Allergies: Penicillin

Current Presentation:

• Chief complaint: Persistent headaches and dizziness

• Key symptoms: Fatigue, occasional chest discomfort, and increased frequency of urination

• Vital signs: Blood pressure 160/100 mmHg, heart rate 88 bpm, respiratory rate 18 breaths per minute, temperature 98.6°F

Section 1

Initial assessment findings reveal that the patient's current antihypertensive regimen may not be effectively controlling her blood pressure, as indicated by her elevated blood pressure of 160/100 mmHg. Her persistent headaches, dizziness, and occasional chest discomfort, coupled with increased frequency of urination, suggest the possibility of developing end-organ damage, potentially affecting her cardiovascular or renal systems. Upon physical examination, the patient exhibits mild retinal changes during fundoscopy, suggesting early hypertensive retinopathy, and slight pedal edema, which could indicate early signs of heart failure.

Further laboratory tests are ordered to evaluate the extent of organ involvement. Serum electrolytes show a slight elevation in creatinine levels at 1.4 mg/dL (normal range: 0.6-1.2 mg/dL), indicating possible renal impairment. The patient's lipid profile reveals elevated LDL cholesterol levels, which further increases her risk for cardiovascular complications. A 12-lead ECG is performed, showing left ventricular hypertrophy, a common adaptation of the heart to chronic high blood pressure, which necessitates additional intervention.

These findings prompt a re-evaluation of her current treatment plan. The healthcare team considers the need to adjust her medication regimen, potentially by increasing the dose of Lisinopril or adding another antihypertensive agent, such as a calcium channel blocker, to better manage her blood pressure and mitigate further complications. This plan will also involve lifestyle modifications, including dietary changes and increased physical activity, to address her hypertension comprehensively and prevent further end-organ damage.

Section 2

In response to the initial assessment and diagnostic findings, the healthcare team implements changes to the patient's treatment plan. The decision is made to add amlodipine, a calcium channel blocker, to her regimen alongside increasing the dose of Lisinopril. These adjustments aim to achieve better blood pressure control and reduce the risk of further cardiovascular complications. The patient is also educated on lifestyle modifications, emphasizing the importance of a low-sodium diet and regular physical activity to support the pharmacological interventions.

Two weeks later, the patient returns for a follow-up appointment. Her blood pressure has decreased to 142/88 mmHg, showing some improvement, although it remains above the target range. Her headaches and dizziness have lessened, but she reports continued occasional chest discomfort. Physical examination reveals that the mild pedal edema persists, and a repeat fundoscopy confirms stable retinal changes without further progression. Laboratory tests are repeated, showing a slight decrease in creatinine levels to 1.3 mg/dL and marginal improvements in her lipid profile, suggesting a positive response to the combined treatment and lifestyle changes.

However, an unexpected new complication arises. The patient reports experiencing increased fatigue and mild shortness of breath upon exertion. These symptoms warrant further investigation, as they could indicate worsening left ventricular function or the development of more pronounced heart failure. An echocardiogram is ordered to assess her cardiac function and guide further management. The healthcare team discusses the potential need for additional treatment adjustments, such as the introduction of a beta-blocker, to provide comprehensive cardiovascular protection and address her evolving clinical status.

Section 3

As the healthcare team reviews the new diagnostic results from the echocardiogram, they discover that the patient's ejection fraction has decreased to 45%, indicating borderline heart failure with reduced ejection fraction (HFrEF). This finding correlates with her symptoms of increased fatigue and mild shortness of breath upon exertion. Despite the improvements in her blood pressure and lipid profile, the new echocardiographic data suggests that her cardiac function is not optimal, necessitating a comprehensive reevaluation of her treatment plan.

The decision is made to add a beta-blocker, specifically carvedilol, to her medication regimen. This adjustment aims to improve her cardiac output, reduce heart rate, and provide additional cardiovascular protection. The healthcare team carefully considers the potential for side effects, such as bradycardia or worsening of her pedal edema, and emphasizes the need for gradual titration of the beta-blocker dose. Concurrently, the patient is advised to monitor her weight daily and report any sudden changes, as these could indicate fluid retention or exacerbation of heart failure symptoms.

To support these pharmacological interventions, the patient is reminded of the importance of adhering to her low-sodium diet and maintaining regular physical activity, with adjustments to accommodate her current exercise tolerance. The team also schedules more frequent follow-up appointments to closely monitor her response to the new treatment strategy and to ensure any further complications are promptly addressed. This coordinated approach aims to stabilize her condition, enhance her quality of life, and prevent further deterioration of her cardiovascular health.

Section 4

Two weeks after the introduction of carvedilol into the patient's treatment regimen, she returns for a follow-up appointment. During the initial assessment, the nurse notes a slight decrease in the patient's resting heart rate, now at 68 beats per minute, reflecting the intended effect of the beta-blocker. However, the patient reports experiencing episodes of dizziness, particularly when standing up quickly, suggesting potential orthostatic hypotension. Her blood pressure is recorded at 110/70 mmHg, which is a notable reduction from previous readings but raises concerns about the balance between achieving optimal cardiac function and maintaining adequate perfusion.

Laboratory tests reveal stable kidney function with a creatinine level of 1.0 mg/dL, but a mild elevation in B-type natriuretic peptide (BNP) to 150 pg/mL, indicating increased ventricular strain. The patient’s weight has remained steady, with no significant fluctuations, and she denies any new onset of dyspnea or worsening pedal edema. This suggests that while fluid retention is under control, her cardiovascular system is still under stress, as evidenced by the elevated BNP.

In light of these findings, the healthcare team deliberates on the need to adjust the carvedilol dose while considering the potential need for additional diuretics if fluid retention becomes a concern. They emphasize the importance of the patient's compliance with her dietary restrictions and physical activity plan to help manage her symptoms and prevent further complications. The team decides to continue close monitoring, with the next follow-up scheduled in two weeks, focusing on assessing her symptoms and titrating the medication to achieve the best therapeutic outcome without compromising her overall stability.

Section 5

Two weeks later, the patient returns for her scheduled follow-up appointment. During the initial assessment, the nurse observes that the patient's blood pressure has decreased further to 100/65 mmHg, and her heart rate is steady at 65 beats per minute. The patient reports persistent dizziness, now accompanied by occasional palpitations, particularly noticeable during physical exertion. Orthostatic blood pressure measurements confirm a significant drop upon standing, reinforcing the suspicion of orthostatic hypotension. Despite these symptoms, the patient maintains adherence to her medication regimen and dietary plans, expressing concern about her ongoing dizziness and its impact on daily activities.

New laboratory results reveal a further increase in BNP levels to 200 pg/mL, suggesting a continued strain on the heart. Electrolyte panels indicate a mild decrease in serum potassium to 3.4 mEq/L, possibly attributed to her current medication regimen. Renal function remains stable with a creatinine level of 1.0 mg/dL, and there is no evidence of new or worsening fluid retention. The patient's weight remains stable, and there is no new onset of dyspnea or significant edema. However, the patient’s electrocardiogram shows occasional premature ventricular contractions, which could be contributing to her palpitations.

In response to these findings, the healthcare team considers adjusting her carvedilol dosage to address the orthostatic hypotension while evaluating the necessity of adding a low-dose potassium-sparing diuretic to manage her potassium levels without exacerbating fluid retention. The team educates the patient on recognizing symptoms of electrolyte imbalance and emphasizes the importance of reporting any new symptoms. They plan to monitor her closely, scheduling more frequent follow-ups to fine-tune her treatment and prevent further cardiovascular complications. This approach aims to balance the management of her hypertension and heart strain while maintaining her quality of life.